Pharma Industry Has Shown ‘Huge Interest’ In AI For Drug Development, Says EMA

The EMA received more than 1,000 responses to its draft reflection paper on AI in drug development, some of which will be incorporated into the final document, an agency representative told this week’s RAPS Euro Convergence 2024.